Atlas Trials

The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma

Clinical trial NCT05774275 · RECRUITING

Trial details

NCT number
NCT05774275
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
High-Risk Localized Soft Tissue Sarcoma
Start date
2022-08-25
Primary completion
2027-08-24
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.